Syndya Therapeutics
Pre-clinicalDevelops small molecule therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Founded
2019
Focus
Diagnostics
About
Develops small molecule therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Funding History
1Total raised: $3M
Seed$3MUndisclosedJan 15, 2022
Company Info
TypePrivate
Founded2019
LocationBasel, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile